What's in PLx Pharma's pipeline?

PLx Pharma has 11 drugs in our index: 2 marketed, 0 filed, 3 in Phase 3, 3 in Phase 2, 3 in Phase 1.

Which companies overlap with PLx Pharma's portfolio?

Top competitors by shared drug class: Assistance Publique - Hôpitaux de Paris, University of Pennsylvania, Azienda Ospedaliera San Giovanni Battista, Barcelona Institute for Global Health, Basque Health Service.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/plx-pharma.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-14 · How we verify

PLx Pharma — Portfolio Competitive Intelligence Brief

PLx Pharma pipeline: 2 marketed, 0 filed, 3 Phase 3, 3 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

2 marketed 0 filed 3 Phase 3 3 Phase 2 3 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area
PL-ASA	PL-ASA	marketed	Antiplatelet agent	Cyclooxygenase-1 (COX-1)	Cardiovascular
Aspirin tablets	Aspirin tablets	marketed	Nonsteroidal anti-inflammatory drug (NSAID); antiplatelet agent	Cyclooxygenase-1 (COX-1); Cyclooxygenase-2 (COX-2)	Cardiovascular; Pain management; Inflammation
PL2200 Aspirin Capsules	PL2200 Aspirin Capsules	phase 3	Antiplatelet agent (aspirin formulation)	Cyclooxygenase-1 (COX-1)	Cardiovascular
Enteric-coated aspirin caplets	Enteric-coated aspirin caplets	phase 3	Antiplatelet agent / NSAID	Cyclooxygenase-1 (COX-1), Cyclooxygenase-2 (COX-2)	Cardiovascular
Immediate-Release Aspirin Tablets	Immediate-Release Aspirin Tablets	phase 3	Nonsteroidal anti-inflammatory drug (NSAID); antiplatelet agent	Cyclooxygenase-1 (COX-1); Cyclooxygenase-2 (COX-2)	Cardiovascular

Therapeutic area mix

Cardiovascular · 4
Cardiovascular; Pain management; Inflammation · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Assistance Publique - Hôpitaux de Paris · 2 shared drug classes
University of Pennsylvania · 2 shared drug classes
Azienda Ospedaliera San Giovanni Battista · 1 shared drug class
Barcelona Institute for Global Health · 1 shared drug class
Basque Health Service · 1 shared drug class
Beijing Tiantan Hospital · 1 shared drug class
Biogen · 1 shared drug class
Baim Institute for Clinical Research · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for PLx Pharma:

Cite this brief

Drug Landscape (2026). PLx Pharma — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/plx-pharma. Accessed 2026-05-14.